Abrezekimab
Product Specifications
CAS Number
2043952-59-4
Target
Interleukin, IL Receptor
Related Pathways
Immunology/Inflammation
Purity
0.9834
Bioactivity
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Rα1 subunit. Abrezekimab can be used to study biological disorders associated with asthma and lung disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1183439-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae Thymidylate synthase (thyA)
Sign In for Pricing
View Details MBS1183439-02 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae Thymidylate synthase (thyA)
Sign In for Pricing
View Details